• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Measuring Physical Activity With Implanted Cardiac Devices: A Systematic Review.植入式心脏设备测量体力活动:系统评价。
J Am Heart Assoc. 2018 May 17;7(11):e008663. doi: 10.1161/JAHA.118.008663.
2
Physical Activity Measured by Implanted Devices Predicts Atrial Arrhythmias and Patient Outcome: Results of IMPLANTED (Italian Multicentre Observational Registry on Patients With Implantable Devices Remotely Monitored).植入设备测量的体力活动可预测心房颤动和患者预后:植入(意大利多中心观察性注册研究,远程监测植入式设备的患者)的结果。
J Am Heart Assoc. 2018 Feb 24;7(5):e008146. doi: 10.1161/JAHA.117.008146.
3
Impact of COVID-19 lockdown in patients with implantable cardioverter and cardiac resynchronization therapy defibrillators: insights from daily remote monitoring transmissions.COVID-19 封锁对植入式心脏转复除颤器和心脏再同步治疗除颤器患者的影响:来自日常远程监测传输的见解。
Heart Vessels. 2021 Nov;36(11):1694-1700. doi: 10.1007/s00380-021-01843-w. Epub 2021 Mar 29.
4
Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.欧洲心脏节律协会卫生经济学委员会关于欧洲心脏植入式电子设备远程监测的实施与报销情况调查
Europace. 2015 May;17(5):814-8. doi: 10.1093/europace/euu390. Epub 2015 Feb 20.
5
Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.心力衰竭合并心房颤动患者心脏再同步治疗的比较效果:来自国家心血管数据注册中心植入式心律转复除颤器注册研究的结果
Circ Heart Fail. 2016 Jun;9(6). doi: 10.1161/CIRCHEARTFAILURE.115.002324.
6
Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.心脏再同步治疗除颤器的电池寿命。
Europace. 2014 Feb;16(2):246-51. doi: 10.1093/europace/eut301. Epub 2013 Oct 6.
7
Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.采用一套新型检测算法减少心脏再同步治疗除颤器治疗的心力衰竭患者不适当的抗心动过速起搏治疗和电击:前瞻性数据库的历史对照研究
Europace. 2016 Sep;18(9):1391-8. doi: 10.1093/europace/euv420. Epub 2016 Jan 29.
8
Mobile health and implantable cardiac devices: Patients' expectations.移动医疗和植入式心脏设备:患者的期望。
Eur J Prev Cardiol. 2019 Jun;26(9):920-927. doi: 10.1177/2047487319830531. Epub 2019 Mar 1.
9
Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.延长器械寿命对植入式心脏转复除颤器治疗长期成本的影响:具有 15 年时间范围的建模研究。
Europace. 2013 Oct;15(10):1453-62. doi: 10.1093/europace/eut133. Epub 2013 May 21.
10
Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.心脏复律除颤器或心脏再同步治疗接受者的并发症:来自西里西亚中心除颤器登记处的见解。
Cardiol J. 2017;24(5):515-522. doi: 10.5603/CJ.a2016.0092. Epub 2016 Oct 13.

引用本文的文献

1
Wearable Devices for Exercise Prescription and Physical Activity Monitoring in Patients with Various Cardiovascular Conditions.用于各种心血管疾病患者运动处方和身体活动监测的可穿戴设备
CJC Open. 2025 Mar 3;7(5):695-706. doi: 10.1016/j.cjco.2025.02.017. eCollection 2025 May.
2
Physical activity benchmarks for implantable loop recorder patients: The role of ILRs in cardiovascular disease management.植入式循环记录仪患者的体力活动基准:ILR在心血管疾病管理中的作用。
Heart Rhythm O2. 2024 Nov 16;6(2):183-187. doi: 10.1016/j.hroo.2024.11.008. eCollection 2025 Feb.
3
Effects of Extreme Humidity and Heat on Ventricular Arrhythmia Risk in Patients With Cardiac Devices.极端湿度和高温对心脏器械植入患者室性心律失常风险的影响
JACC Adv. 2024 Dec 13;4(1):101463. doi: 10.1016/j.jacadv.2024.101463. eCollection 2025 Jan.
4
Relevance of patient-centered actigraphy measures in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a qualitative interview study.以患者为中心的活动记录仪测量在肺动脉高压和慢性血栓栓塞性肺动脉高压中的相关性:一项定性访谈研究
BMC Pulm Med. 2024 Dec 18;24(1):608. doi: 10.1186/s12890-024-03442-7.
5
Summary of the best evidence for risk stratification of exercise rehabilitation in patients with a cardiac implantable electronic device.心脏植入式电子设备患者运动康复风险分层的最佳证据总结。
Front Cardiovasc Med. 2024 Nov 25;11:1455486. doi: 10.3389/fcvm.2024.1455486. eCollection 2024.
6
Deep behavioural representation learning reveals risk profiles for malignant ventricular arrhythmias.深度行为表征学习揭示恶性室性心律失常的风险特征。
NPJ Digit Med. 2024 Sep 16;7(1):250. doi: 10.1038/s41746-024-01247-w.
7
Ambulatory Risk Stratification for Worsening Heart Failure in Patients with Reduced and Preserved Ejection Fraction Using Diagnostic Parameters Available in Implantable Cardiac Monitors.使用植入式心脏监测器中可用的诊断参数对射血分数降低和保留的心力衰竭患者进行门诊风险分层,以评估心力衰竭恶化情况
Diagnostics (Basel). 2024 Apr 5;14(7):771. doi: 10.3390/diagnostics14070771.
8
Current state of the art and future directions for implantable sensors in medical technology: Clinical needs and engineering challenges.医学技术中可植入传感器的当前技术水平与未来发展方向:临床需求与工程挑战。
APL Bioeng. 2023 Sep 27;7(3):031506. doi: 10.1063/5.0152290. eCollection 2023 Sep.
9
ehealth technology in cardiac exercise therapeutics for pediatric patients with congenital and acquired heart conditions: a summary of evidence and future directions.先天性和后天性心脏病患儿心脏运动治疗中的电子健康技术:证据总结与未来方向
Front Cardiovasc Med. 2023 Jun 2;10:1155861. doi: 10.3389/fcvm.2023.1155861. eCollection 2023.
10
Onset of the COVID-19 pandemic reduced active time in patients with implanted cardiac devices.新冠疫情的爆发减少了植入心脏设备患者的活动时间。
Eur Rev Aging Phys Act. 2022 Nov 2;19(1):26. doi: 10.1186/s11556-022-00305-0.

本文引用的文献

1
Patient Activity Decreases and Mortality Increases After the Onset of Persistent Atrial Fibrillation in Patients With Implantable Cardioverter-Defibrillators.植入式心脏复律除颤器患者发生持续性心房颤动后,患者活动减少,死亡率增加。
JACC Clin Electrophysiol. 2016 Aug;2(4):518-523. doi: 10.1016/j.jacep.2016.01.015. Epub 2016 Apr 6.
2
No Further Question: Cardiac Rehabilitation Benefits Patients With Implantable-Cardioverter Defibrillators: Insurers, Are You Listening?不再有疑问:心脏康复对植入式心脏复律除颤器患者有益:保险公司,你们在听吗?
JACC Clin Electrophysiol. 2017 Feb;3(2):127-128. doi: 10.1016/j.jacep.2016.09.010. Epub 2016 Nov 30.
3
Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator: A Meta-Analysis.运动训练对植入式心脏复律除颤器患者的安全性和疗效:一项荟萃分析。
JACC Clin Electrophysiol. 2017 Feb;3(2):117-126. doi: 10.1016/j.jacep.2016.06.008. Epub 2016 Sep 7.
4
It's My Heart: Why Not My Data?这是我的心脏:为何不是我的数据?
Circulation. 2018 Jan 2;137(1):4-6. doi: 10.1161/CIRCULATIONAHA.117.031392.
5
Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial.除颤器电击及其对客观和主观患者结局的影响:PainFree SST 临床试验结果。
Heart Rhythm. 2018 May;15(5):734-740. doi: 10.1016/j.hrthm.2017.12.026. Epub 2017 Dec 24.
6
How active are young cardiac device patients? Objective assessment of activity in children with cardiac devices.植入心脏设备的年轻患者活动量如何?对植入心脏设备儿童的活动情况进行客观评估。
Pacing Clin Electrophysiol. 2017 Nov;40(11):1286-1290. doi: 10.1111/pace.13197. Epub 2017 Oct 10.
7
Predictive value of device-derived activity level for short-term outcomes in MADIT-CRT.在 MADIT-CRT 中,设备检测到的活动水平对短期预后的预测价值。
Heart Rhythm. 2017 Jul;14(7):1081-1086. doi: 10.1016/j.hrthm.2017.03.032. Epub 2017 Mar 25.
8
A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study.多传感器算法预测植入设备患者的心力衰竭事件:MultiSENSE 研究结果。
JACC Heart Fail. 2017 Mar;5(3):216-225. doi: 10.1016/j.jchf.2016.12.011.
9
Frailty, Physical Activity, and Mobility in Patients With Cardiac Implantable Electrical Devices.心脏植入式电子设备患者的衰弱、身体活动与运动能力
J Am Heart Assoc. 2017 Feb 10;6(2):e004659. doi: 10.1161/JAHA.116.004659.
10
Association between patient activity and long-term cardiac death in patients with implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators.植入式心脏复律除颤器和心脏再同步治疗除颤器患者的活动与长期心源性死亡之间的关联。
Eur J Prev Cardiol. 2017 May;24(7):760-767. doi: 10.1177/2047487316688982. Epub 2017 Jan 24.

植入式心脏设备测量体力活动:系统评价。

Measuring Physical Activity With Implanted Cardiac Devices: A Systematic Review.

机构信息

Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT

Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT.

出版信息

J Am Heart Assoc. 2018 May 17;7(11):e008663. doi: 10.1161/JAHA.118.008663.

DOI:10.1161/JAHA.118.008663
PMID:29773575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6015387/
Abstract

BACKGROUND

Physical activity is predictive of cardiovascular outcomes in patients with cardiovascular implantable electronic devices, yet it is not regularly assessed in routine care. Current-generation cardiovascular implantable electronic devices, however, continuously monitor patient activity through a built-in accelerometer, which provides new opportunities to remotely assess patient activity, detect changes in clinical status, and incorporate these data in risk stratification models. This review critically examines the literature on device-measured physical activity (D-PA), with a focus on identifying methodological issues that may affect interpretation of study results.

METHODS AND RESULTS

We conducted a systematic review of D-PA studies published from January 1 1995 to December 30 2017, identifying 29 studies meeting inclusion criteria, 5 of which were validation reports. Few technical details about D-PA sensors are reported, and procedures for analyzing and interpreting D-PA data are heterogeneous. Trends in D-PA over time and associations with clinical outcomes were reported by 22 studies, and in 7 studies, D-PA was combined with other device parameters in risk stratification models, demonstrating modest-to-good sensitivity in predicting acute heart failure decompensation, hospitalization, and mortality.

CONCLUSIONS

Current evidence suggests that D-PA may be useful for assessing physical activity and predicting clinical outcomes in patients with cardiovascular implantable electronic devices when combined with other device parameters. Future work must address challenges related to D-PA data measurement, interpretation, and generalizability to support expanded clinical applications of this technology.

摘要

背景

体力活动可预测心血管植入电子设备患者的心血管结局,但在常规护理中并未定期评估。然而,当前代心血管植入电子设备通过内置加速度计连续监测患者的活动,这为远程评估患者活动、检测临床状况变化以及将这些数据纳入风险分层模型提供了新的机会。本综述批判性地审查了关于设备测量体力活动(D-PA)的文献,重点是确定可能影响研究结果解释的方法学问题。

方法和结果

我们对 1995 年 1 月 1 日至 2017 年 12 月 30 日期间发表的 D-PA 研究进行了系统评价,确定了符合纳入标准的 29 项研究,其中 5 项为验证报告。很少有关于 D-PA 传感器的技术细节报告,并且分析和解释 D-PA 数据的程序存在异质性。22 项研究报告了 D-PA 随时间的变化趋势及其与临床结局的关联,7 项研究将 D-PA 与其他设备参数结合用于风险分层模型,证明了其在预测急性心力衰竭失代偿、住院和死亡率方面具有适度至良好的敏感性。

结论

目前的证据表明,当与其他设备参数结合使用时,D-PA 可能有助于评估心血管植入电子设备患者的体力活动和预测临床结局。未来的工作必须解决与 D-PA 数据测量、解释和推广性相关的挑战,以支持该技术的广泛临床应用。